Cargando…
A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal malignancies worldwide. PDAC prognostic and diagnostic biomarkers are still being explored. The aim of this study is to establish a robust molecular signature that can improve the ability to predict PDAC prognosis. 155 overlapping diff...
Autores principales: | Zhou, Chenhao, Zhao, Yue, Yin, Yirui, Hu, Zhiqiu, Atyah, Manar, Chen, Wanyong, Meng, Zhefeng, Mao, Huarong, Zhou, Qiang, Tang, Weiguo, Wang, Pengcheng, Li, Zhanming, Weng, Jialei, Bruns, Christiane, Popp, Marie, Popp, Felix, Dong, Qiongzhu, Ren, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775308/ https://www.ncbi.nlm.nih.gov/pubmed/31595147 http://dx.doi.org/10.7150/ijbs.32899 |
Ejemplares similares
-
Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021) -
The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients
por: Atyah, Manar, et al.
Publicado: (2022) -
A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019) -
Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma
por: Chen, Wanyong, et al.
Publicado: (2018) -
Low expression of WW domain‐containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2018)